MALIGNANT PERIPHERAL NERVE SHEATH TUMOR (MPNST)
Clinical trials for MALIGNANT PERIPHERAL NERVE SHEATH TUMOR (MPNST) explained in plain language.
Never miss a new study
Get alerted when new MALIGNANT PERIPHERAL NERVE SHEATH TUMOR (MPNST) trials appear
Sign up with your email to follow new studies for MALIGNANT PERIPHERAL NERVE SHEATH TUMOR (MPNST), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for tough cancers: trial tests Immune-Boosting drug with chemo
Disease control Recruiting nowThis study is testing whether adding a new immunotherapy drug called tislelizumab to standard chemotherapy works better for people with advanced soft tissue sarcoma. It will enroll 45 adults with specific types of sarcoma that cannot be removed by surgery or have spread. The main…
Matched conditions: MALIGNANT PERIPHERAL NERVE SHEATH TUMOR (MPNST)
Phase: PHASE2 • Sponsor: Fudan University • Aim: Disease control
Last updated Mar 17, 2026 13:10 UTC
-
New hope for kids with tough cancers: trial tests 'Living Drug'
Disease control Recruiting nowThis study is testing a new personalized cell therapy called afamitresgene autoleucel in children and young adults with advanced cancers like sarcoma and neuroblastoma. The main goals are to see if the treatment is safe and if it can shrink tumors. Researchers will enroll up to 2…
Matched conditions: MALIGNANT PERIPHERAL NERVE SHEATH TUMOR (MPNST)
Phase: PHASE1, PHASE2 • Sponsor: USWM CT, LLC • Aim: Disease control
Last updated Mar 17, 2026 13:08 UTC